American Journal of Transplantation: Volume 16, Number 11, November 2016

On the cover this month: In 2011, belatacept was approved for use in kidney transplantation. Though its uptake by the transplant community has been gradual, owing at least in part to the many new mechanistic and logistical paradigms associated with its use, it is gaining a foothold in clinical practice. This month we feature several articles relevant to the growing use and acceptance of belatacept in clinical transplantation, including the final results of the pivotal BENEFIT‐EXT study (Durrbach et al, page 3192), a registry analysis of postapproval use of belatacept (Wen et al, page 3202), and two articles describing expanded clinical use of belatacept. Ebcioglu et al ( page 3278) describe belatacept use in an HIV‐positive patient, and Krezdorn et al ( page 3305) report on the use of belatacept in face transplantation. Also this month, we present the “What's Hot, What's New” summary of the 2016 American Transplant Congress (Levitsky and Gill, page 3105), and an overview article from the ASTS Scientific Studies Committee (Fayek et al, page 3093) with a useful summary of the SRTR data on liver transplantation. Cover design by Lauren Halligan, Duke University Department of Surgery .